The European Commission has authorized the marketing of the drug “Tizild,” which slows the progression of type 1 diabetes, within the European Union, according to an announcement by the French company (Sanofi), the drug’s manufacturer. The…
Read moreA recent scientific study conducted in Uganda has revealed new biomarkers and genetic markers that may help doctors diagnose type 2 diabetes more accurately in people of African descent, in a move that highlights the shortcomings of internationally accepted…
Read more
Despite medical progress and the expansion of screening programs, millions of people around the world still live with diabetes without realizing they have it. In the United States alone, data from the Centers for Disease Control and Prevention indicates that…
Read more
Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s resubmission of the New Drug Application (NDA) for Oclaiz (CAM2029), octreotide extended-release injection, for the treatment…
Read more
